160 related articles for article (PubMed ID: 10594732)
1. Selective incorporation and specific cytocidal effect as the cellular basis for the antimelanoma action of sulphur containing tyrosine analogs.
Thomas PD; Kishi H; Cao H; Ota M; Yamashita T; Singh S; Jimbow K
J Invest Dermatol; 1999 Dec; 113(6):928-34. PubMed ID: 10594732
[TBL] [Abstract][Full Text] [Related]
2. Comparison of in vitro cytotoxicity of N-acetyl and N-propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity.
Gili A; Thomas PD; Ota M; Jimbow K
Melanoma Res; 2000 Feb; 10(1):9-15. PubMed ID: 10711635
[TBL] [Abstract][Full Text] [Related]
3. [Development of targeted chemoradiotherapy for malignant melanoma by exploitation of metabolic pathway].
Jimbow K
Hokkaido Igaku Zasshi; 1998 Mar; 73(2):105-10. PubMed ID: 9612704
[TBL] [Abstract][Full Text] [Related]
4. Sulfur containing tyrosine analogs can cause selective melanocytotoxicity involving tyrosinase-mediated apoptosis.
Minamitsuji Y; Toyofuku K; Sugiyama S; Yamada K; Jimbow K
J Investig Dermatol Symp Proc; 1999 Sep; 4(2):130-6. PubMed ID: 10536987
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumour effect of the melanogenesis-based antimelanoma agent N-propionyl-4-S-cysteaminylphenol.
Tandon M; Thomas PD; Shokravi M; Singh S; Samra S; Chang D; Jimbow K
Biochem Pharmacol; 1998 Jun; 55(12):2023-9. PubMed ID: 9714323
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimelanoma activity of analogues of N-acetyl-4-S-cysteaminylphenol.
Lant NJ; McKeown P; Kelland LR; Rogers PM; Robins DJ
Anticancer Drug Des; 2000 Aug; 15(4):295-302. PubMed ID: 11200505
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antimelanoma activity of sterically congested tertiary amide analogues of N-acetyl-4-S-cysteaminylphenol.
Ferguson J; Rogers PM; Kelland LR; Robins DJ
Oncol Res; 2005; 15(2):87-94. PubMed ID: 16119006
[TBL] [Abstract][Full Text] [Related]
8. Thymidylate synthase as a target enzyme for the melanoma-specific toxicity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenol.
Prezioso JA; Wang N; Bloomer WD
Cancer Chemother Pharmacol; 1992; 30(5):394-400. PubMed ID: 1505078
[TBL] [Abstract][Full Text] [Related]
9. Antimelanoma effect of 4-S-cysteaminylcatechol, an activated form of 4-S-cysteaminylphenol.
Inoue S; Hasegawa K; Ito S; Ozeki H; Solano F; Jiménez-Cervantes C; Wakamatsu K; Fujita K
Cancer Res; 1995 Jun; 55(12):2603-7. PubMed ID: 7780975
[TBL] [Abstract][Full Text] [Related]
10. Selective in vivo accumulation of N-acetyl-4-S-cysteaminylphenol in B16F10 murine melanoma and enhancement of its in vitro and in vivo antimelanoma effect by combination of buthionine sulfoximine.
Alena F; Iwashina T; Gili A; Jimbow K
Cancer Res; 1994 May; 54(10):2661-6. PubMed ID: 8168094
[TBL] [Abstract][Full Text] [Related]
11. N-propionyl-cysteaminylphenol-magnetite conjugate (NPrCAP/M) is a nanoparticle for the targeted growth suppression of melanoma cells.
Sato M; Yamashita T; Ohkura M; Osai Y; Sato A; Takada T; Matsusaka H; Ono I; Tamura Y; Sato N; Sasaki Y; Ito A; Honda H; Wakamatsu K; Ito S; Jimbow K
J Invest Dermatol; 2009 Sep; 129(9):2233-41. PubMed ID: 19295615
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of putative neo-antigen formation from N-propionyl-4-S-cysteaminylphenol, a tyrosinase substrate, in melanoma models.
Ito S; Nishigaki A; Ishii-Osai Y; Ojika M; Wakamatsu K; Yamashita T; Tamura Y; Ito A; Honda H; Nakayama E; Jimbow K
Biochem Pharmacol; 2012 Sep; 84(5):646-53. PubMed ID: 22728921
[TBL] [Abstract][Full Text] [Related]
13. N-propionyl-4-S-cysteaminylphenol induces apoptosis in B16F1 cells and mediates tumor-specific T-cell immune responses in a mouse melanoma model.
Ishii-Osai Y; Yamashita T; Tamura Y; Sato N; Ito A; Honda H; Wakamatsu K; Ito S; Nakayama E; Okura M; Jimbow K
J Dermatol Sci; 2012 Jul; 67(1):51-60. PubMed ID: 22622238
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anti-melanoma activity of analogues of N-acetyl-4-S-cysteaminylphenol substituted with two methyl groups alpha to the nitrogen.
Lant NJ; McKeown P; Timoney MC; Kelland LR; Rogers PM; Robins DJ
Anticancer Drug Des; 2001 Feb; 16(1):49-55. PubMed ID: 11762644
[TBL] [Abstract][Full Text] [Related]
15. Effects of tyrosinase activity on the cytotoxicity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenol in melanoma cells.
Prezioso JA; Epperly MW; Wang N; Bloomer WD
Cancer Lett; 1992 Mar; 63(1):73-9. PubMed ID: 1555210
[TBL] [Abstract][Full Text] [Related]
16. The in vivo antimelanoma effect of 4-S-cysteaminylphenol and its n-acetyl derivative.
Miura T; Jimbow K; Ito S
Int J Cancer; 1990 Nov; 46(5):931-4. PubMed ID: 2121652
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antimelanoma activity of reversed amide analogues of N-acetyl-4-S-cysteaminylphenol.
Nicoll K; Robertson J; Lant N; Kelland LR; Rogers PM; Robins DJ
Oncol Res; 2006; 16(2):97-106. PubMed ID: 16898270
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antimelanoma activity of tertiary amide analogues of N-acetyl-4-S-cysteaminylphenol.
Pearson VC; Ferguson J; Rogers PM; Kelland LR; Robins DJ
Oncol Res; 2003; 13(11):503-12. PubMed ID: 12812364
[TBL] [Abstract][Full Text] [Related]
19. Action of cysteaminylphenols on human melanoma cells in vivo and in vitro: 4-S-cysteaminylphenol binds protein disulphide isomerase.
Parsons PG; Favier D; McEwan M; Takahashi H; Jimbow K; Ito S
Melanoma Res; 1991; 1(2):97-104. PubMed ID: 1823629
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and selective in vitro anti-melanoma effect of enantiomeric alpha-methyl- and alpha-ethyl-4-S-cysteaminylphenol.
Yukitake J; Otake H; Inoue S; Wakamatsu K; Olivares C; Solano F; Hasegawa K; Ito S
Melanoma Res; 2003 Dec; 13(6):603-9. PubMed ID: 14646624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]